Evidence map›Paper›PMID 42058759›Full record

ArticleInternational journal of cardiology. Heart & vasculature2026

Cardiac dysfunction after acute ischaemic stroke: Long-term outcomes from the SICFAIL cohort.

Kathrin Ungethüm, Felipe A Montellano, Viktoria Rücker, Timo Ludwig, Charles D A Wolfe, Caroline Morbach, Stefan Frantz, Stefan Störk, Christoph Kleinschnitz, Karl Georg Haeusler and 2 more

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathrin UngethümInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Felipe A MontellanoInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Viktoria RückerInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Timo LudwigInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Charles D A WolfeDepartment of Population Health Sciences, King's College London, London, United Kingdom.
Caroline MorbachDepartment of Epidemiology and Clinical Research, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Stefan FrantzDepartment of Epidemiology and Clinical Research, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Stefan StörkDepartment of Epidemiology and Clinical Research, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Christoph KleinschnitzDepartment of Neurology, University Hospital Essen, Essen, Germany.
Karl Georg HaeuslerDepartment of Neurology, University Hospital Ulm, Ulm, Germany.
Peter U HeuschmannInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
SICFAIL study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systolic dysfunction, diastolic dysfunction, and clinically overt heart failure are frequently encountered after acute ischaemic stroke. We investigated whether these cardiac phenotypes, considered as distinct entities, are associated with readmission and death within two years after stroke in the prospective SICFAIL cohort. Methods: Adults with acute ischaemic stroke were consecutively enrolled between 01/2014 and 02/2017. Cardiac function was assessed at baseline, and patients were followed annually by mail or telephone. The primary endpoint was the composite of all-cause readmission or death. Secondary analyses considered individual endpoints and cardiovascular readmissions. Associations were estimated using multivariable Cox proportional hazards models. Results: Of 696 enrolled patients, 644 (92.5%) had interpretable echocardiographic data. During two-year follow-up, 206 of 554 patients (37.1%) with complete outcome information were rehospitalised, and 63 of 577 patients (11.4%) with available vital status data died. After adjustment, systolic dysfunction and clinically overt heart failure were independently associated with the composite endpoint (systolic dysfunction: hazard ratio [HR] 1.97 (95% confidence interval [CI], 1.34-2.91); clinically overt heart failure: HR 1.62, 95% CI 1.02-2.58). Systolic dysfunction also predicted cardiovascular readmissions (HR 2.27, 95% CI 1.22-4.21). Diastolic dysfunction was not associated with adverse outcomes. Conclusion: In this cohort, systolic dysfunction and clinically overt heart failure at the time of ischaemic stroke independently predicted the composite of readmission or death over the subsequent two years, whereas isolated diastolic dysfunction was not prognostically informative. Routine echocardiographic assessment after stroke may therefore help identify patients who would benefit from intensified cardiac follow‑up and secondary prevention.

Indexed as

Heart FailureIschaemic StrokeStroke OutcomeSystolic Dysfunction

Identifiers

PMID42058759
PMCPMC13122669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.